SCHEMBL19913332

SCHEMBL19913332

N#Cc1cc(-n2c3ccccc3c3cc(-c4ccccc4-c4ccccc4)ccc32)c(-c2ccncc2)c(-n2c3ccccc3c3cc(-c4ccccc4-c4ccccc4)ccc32)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SQOR Q9Y6N5 1/20 0.37
METAP2 P50579 1/20 0.36
MAPK14 Q16539 5/20 0.35
PIK3CA P42336 1/20 0.35
CYP19A1 P11511 1/20 0.34
CYP11B1 P15538 1/20 0.34
CYP11B2 P19099 1/20 0.34
CSNK1A1 P48729 1/20 0.34
CSNK1D P48730 1/20 0.34
MAPK13 O15264 1/20 0.34
RAF1 P04049 1/20 0.34
MAPK12 P53778 1/20 0.34
MAPK11 Q15759 1/20 0.34
MET P08581 1/20 0.33
FLT3 P36888 2/20 0.33
ABCG2 Q9UNQ0 1/20 0.33
ALDH1A1 P00352 1/20 0.33
ATM Q13315 1/20 0.33
USP2 O75604 1/20 0.33
CYP1A2 P05177 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19913335 0.94 SQOR (0.37) SQORMETAP2MAPK14PIK3CACYP19A1
SCHEMBL19909350 0.92 MAPK14 (0.39) SQORMAPK14PIK3CACSNK1A1CSNK1D
SCHEMBL19908924 0.90 CYP1A2 (0.37) MAPK14FLT3ALDH1A1USP2CYP1A2
SCHEMBL19913147 0.89 MAPK14 (0.37) MAPK14CYP11B1CYP11B2CSNK1A1CSNK1D
SCHEMBL19908921 0.89 MKNK1 (0.40) MAPK14PIK3CACYP19A1CYP11B2CSNK1A1
SCHEMBL19913173 0.88 ABCG2 (0.41) SQORMAPK14CSNK1A1CSNK1DMAPK13
SCHEMBL19909475 0.88 CYP1A2 (0.40) MAPK14FLT3ABCG2ALDH1A1USP2
SCHEMBL19908925 0.88 MAPK14 (0.39) MAPK14CYP11B2CSNK1A1CSNK1DMAPK13
SCHEMBL19909114 0.88 MAPK14 (0.39) MAPK14CSNK1A1CSNK1DFLT3ABCG2
SCHEMBL21757798 0.87 MAPK14 (0.40) SQORMAPK14CYP19A1CYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588114-B2 Organic molecules for use in optoelectronic devices SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-21 US disclosed
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-07-02 US disclosed
US-10665792-B2 Organic molecules for use in optoelectronic devices CYNORA GMBH (DE) 2020-05-26 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, OPRM1, OR51E2 SQOR 1580/4885METAP2 2365/4885MAPK14 2544/4885
US-10665792-B2 Organic molecules for use in optoelectronic devices OR10J3, CFD, AOX1 SQOR 225/4885METAP2 3353/4885MAPK14 2787/4885
US-11588114-B2 Organic molecules for use in optoelectronic devices OR10J3, OPRM1, OR51E2 SQOR 1580/4885METAP2 2365/4885MAPK14 2544/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.